You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

VYNE and Tay Therapeutics reach licence agreement

University of Dundee-based Tay Therapeutics – a company focused on developing small molecules for oncology – has announced that it has reached an exclusive licence agreement with VYNE Therapeutics.